
Phi Hoang
Examiner (ID: 1921, Phone: (571)270-3417 , Office: P/2613 )
| Most Active Art Unit | 2613 |
| Art Unit(s) | 2678, 2619, 2628, 2613, 4178 |
| Total Applications | 1057 |
| Issued Applications | 820 |
| Pending Applications | 71 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11528564
[patent_doc_number] => 20170088542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'QUINOLINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/373091
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34444
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15373091
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/373091 | Quinoline derivative | Dec 7, 2016 | Issued |
Array
(
[id] => 14336931
[patent_doc_number] => 20190150438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => CONFIGURATIONAL STEREOISOMER OF DIFETHIALONE, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
[patent_app_type] => utility
[patent_app_number] => 16/061062
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061062 | CONFIGURATIONAL STEREOISOMER OF DIFETHIALONE, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS | Dec 5, 2016 | Abandoned |
Array
(
[id] => 13621885
[patent_doc_number] => 20180362494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => CONFIGURATIONAL STEREOISOMER OF DIFETHIALONE, COMPOSITION AND RODENTICIDAL BAIT COMPRISING SAME, AND PROCESS FOR CONTROLLING TARGET RODENT PESTS
[patent_app_type] => utility
[patent_app_number] => 16/061084
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061084
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061084 | Configurational stereoisomer of difethialone, composition and rodenticidal bait comprising same, and process for controlling target rodent pests | Dec 5, 2016 | Issued |
Array
(
[id] => 15694243
[patent_doc_number] => 10603282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine
[patent_app_type] => utility
[patent_app_number] => 15/780142
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7375
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780142
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780142 | Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine | Nov 28, 2016 | Issued |
Array
(
[id] => 14171609
[patent_doc_number] => 10259799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Hydroxyl pyranone compound, method for producing same, and cosmetics composition comprising compound
[patent_app_type] => utility
[patent_app_number] => 15/780412
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3299
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780412
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780412 | Hydroxyl pyranone compound, method for producing same, and cosmetics composition comprising compound | Nov 27, 2016 | Issued |
Array
(
[id] => 16213836
[patent_doc_number] => 10729628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Tyrosinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/065202
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4335
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065202 | Tyrosinase inhibitors | Nov 22, 2016 | Issued |
Array
(
[id] => 16252035
[patent_doc_number] => 20200261409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => METHODS FOR PAIN TREATMENT USING RESINIFERATOXIN
[patent_app_type] => utility
[patent_app_number] => 15/776239
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/776239 | METHODS FOR PAIN TREATMENT USING RESINIFERATOXIN | Nov 17, 2016 | Abandoned |
Array
(
[id] => 11649095
[patent_doc_number] => 20170144996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'INHIBITORS OF CXCR2'
[patent_app_type] => utility
[patent_app_number] => 15/353949
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29670
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15353949
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/353949 | Inhibitors of CXCR2 | Nov 16, 2016 | Issued |
Array
(
[id] => 11649096
[patent_doc_number] => 20170144997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'MODULATORS OF CHEMOKINE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 15/353889
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 47393
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15353889
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/353889 | Modulators of chemokine receptors | Nov 16, 2016 | Issued |
Array
(
[id] => 16244881
[patent_doc_number] => 10744209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Biodegradable polymeric nanoparticle conjugates and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/775575
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 12443
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775575 | Biodegradable polymeric nanoparticle conjugates and use thereof | Nov 10, 2016 | Issued |
Array
(
[id] => 14849573
[patent_doc_number] => 10413490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Deodorant compositions
[patent_app_type] => utility
[patent_app_number] => 16/064081
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 3387
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064081
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064081 | Deodorant compositions | Nov 9, 2016 | Issued |
Array
(
[id] => 11619660
[patent_doc_number] => 20170129847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'PROCESS FOR THE REDUCTIVE AMINATION OF HALOGEN-CONTAINING SUBSTRATES'
[patent_app_type] => utility
[patent_app_number] => 15/344846
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17391
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15344846
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/344846 | Process for the reductive amination of halogen-containing substrates | Nov 6, 2016 | Issued |
Array
(
[id] => 15051133
[patent_doc_number] => 10455839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Pre-plant biocide uses of aqueous cyanamides
[patent_app_type] => utility
[patent_app_number] => 15/773742
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 12006
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15773742
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/773742 | Pre-plant biocide uses of aqueous cyanamides | Nov 6, 2016 | Issued |
Array
(
[id] => 13137605
[patent_doc_number] => 10086114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Antimicrobial solutions with enhanced stability
[patent_app_type] => utility
[patent_app_number] => 15/344113
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8611
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15344113
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/344113 | Antimicrobial solutions with enhanced stability | Nov 3, 2016 | Issued |
Array
(
[id] => 12105157
[patent_doc_number] => 09861623
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-01-09
[patent_title] => 'Combination treatment of RAS-positive diseases with PDE-δ inhibitor and direct autophagy inhibitor'
[patent_app_type] => utility
[patent_app_number] => 15/337293
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 54
[patent_no_of_words] => 12002
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337293 | Combination treatment of RAS-positive diseases with PDE-δ inhibitor and direct autophagy inhibitor | Oct 27, 2016 | Issued |
Array
(
[id] => 12210973
[patent_doc_number] => 09907764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine'
[patent_app_type] => utility
[patent_app_number] => 15/299186
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6224
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299186
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299186 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine | Oct 19, 2016 | Issued |
Array
(
[id] => 11555141
[patent_doc_number] => 20170101387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => '1,3,4-Oxadiazole and 1,3,4-Thiadiazole Derivatives as Immunomodulators'
[patent_app_type] => utility
[patent_app_number] => 15/296292
[patent_app_country] => US
[patent_app_date] => 2016-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8712
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15296292
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/296292 | 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators | Oct 17, 2016 | Issued |
Array
(
[id] => 11722291
[patent_doc_number] => 09695138
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-07-04
[patent_title] => 'Phenothiazine derivatives and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 15/295769
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22137
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295769 | Phenothiazine derivatives and methods of use thereof | Oct 16, 2016 | Issued |
Array
(
[id] => 17177314
[patent_doc_number] => 11154543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => P38 MAP kinase inhibitors for wound healing
[patent_app_type] => utility
[patent_app_number] => 15/768483
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 10515
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768483
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768483 | P38 MAP kinase inhibitors for wound healing | Oct 16, 2016 | Issued |
Array
(
[id] => 14818281
[patent_doc_number] => 10406125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
[patent_app_type] => utility
[patent_app_number] => 15/768468
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 11702
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768468
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768468 | Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject | Oct 13, 2016 | Issued |